28057660|t|Protocol for intraoperative assessment of the human cerebrovascular glycocalyx
28057660|a|Adequate functioning of the blood-brain barrier (BBB) is important for brain homoeostasis and normal neuronal function. Disruption of the BBB has been described in several neurological diseases. Recent reports suggest that an increased permeability of the BBB also contributes to increased seizure susceptibility in patients with epilepsy. The endothelial glycocalyx is coating the luminal side of the endothelium and can be considered as the first barrier of the BBB. We hypothesise that an altered glycocalyx thickness plays a role in the aetiology of temporal lobe epilepsy (TLE), the most common type of epilepsy. Here, we propose a protocol that allows intraoperative assessment of the cerebrovascular glycocalyx thickness in patients with TLE and assess whether its thickness is decreased in patients with TLE when compared with controls. This protocol is designed as a prospective observational case-control study in patients who undergo resective brain surgery as treatment for TLE. Control subjects are patients without a history of epileptic seizures, who undergo a craniotomy or burr hole surgery for other indications. Intraoperative glycocalyx thickness measurements of sublingual, cortical and hippocampal microcirculation are performed by video microscopy using sidestream dark-field imaging. Demographic details, seizure characteristics, epilepsy risk factors, intraoperative haemodynamic parameters and histopathological evaluation are additionally recorded. This protocol has been ethically approved by the local medical ethical committee (ID: NL51594.068.14) and complies with the Declaration of Helsinki and principles of Good Clinical Practice. Informed consent is obtained before study enrolment and only coded data will be stored in a secured database, enabling an audit trail. Results will be submitted to international peer-reviewed journals and presented at international conferences. NTR5568.
28057660	0	8	Protocol	T170	C2348563
28057660	13	27	intraoperative	T079	C0456904
28057660	28	38	assessment	T062	C0936012
28057660	46	51	human	T016	C0086418
28057660	52	67	cerebrovascular	T080	C1880018
28057660	68	78	glycocalyx	T026	C0061622
28057660	79	87	Adequate	T080	C0205411
28057660	88	99	functioning	T169	C0542341
28057660	107	126	blood-brain barrier	T042	C1305865
28057660	128	131	BBB	T042	C1305865
28057660	150	155	brain	T023	C0006104
28057660	156	168	homoeostasis	T038	C0019868
28057660	180	188	neuronal	T025	C0027882
28057660	189	197	function	T043	C0007613
28057660	199	209	Disruption	T169	C0332453
28057660	217	220	BBB	T042	C1305865
28057660	251	272	neurological diseases	T047	C0027765
28057660	281	288	reports	T170	C0684224
28057660	305	314	increased	T081	C0205217
28057660	315	327	permeability	T043	C0007605
28057660	335	338	BBB	T023	C0005854
28057660	359	368	increased	T081	C0205217
28057660	369	376	seizure	T184	C0036572
28057660	377	391	susceptibility	T201	C0012655
28057660	395	403	patients	T101	C0030705
28057660	409	417	epilepsy	T047	C0014544
28057660	423	434	endothelial	T024	C0014257
28057660	435	445	glycocalyx	T026	C0061622
28057660	449	456	coating	T080	C1522408
28057660	461	473	luminal side	T082	C0524462
28057660	481	492	endothelium	T024	C0014257
28057660	528	535	barrier	T033	C1704511
28057660	543	546	BBB	T042	C1305865
28057660	551	562	hypothesise	T078	C1512571
28057660	579	589	glycocalyx	T026	C0061622
28057660	590	599	thickness	T080	C1280412
28057660	620	629	aetiology	T169	C1314792
28057660	633	655	temporal lobe epilepsy	T047	C0014556
28057660	657	660	TLE	T047	C0014556
28057660	687	695	epilepsy	T047	C0014544
28057660	716	724	protocol	T170	C2348563
28057660	737	751	intraoperative	T079	C0456904
28057660	752	762	assessment	T062	C0936012
28057660	770	785	cerebrovascular	T080	C1880018
28057660	786	796	glycocalyx	T026	C0061622
28057660	797	806	thickness	T080	C1280412
28057660	810	818	patients	T101	C0030705
28057660	824	827	TLE	T047	C0014556
28057660	851	860	thickness	T080	C1280412
28057660	864	873	decreased	T081	C0205216
28057660	877	885	patients	T101	C0030705
28057660	891	894	TLE	T047	C0014556
28057660	900	908	compared	T052	C1707455
28057660	914	922	controls	T096	C0009932
28057660	929	937	protocol	T170	C2348563
28057660	955	999	prospective observational case-control study	T062	C0007328
28057660	1003	1011	patients	T101	C0030705
28057660	1024	1047	resective brain surgery	T061	C0195960
28057660	1051	1060	treatment	T061	C0087111
28057660	1065	1068	TLE	T047	C0014556
28057660	1070	1086	Control subjects	T096	C0009932
28057660	1091	1099	patients	T101	C0030705
28057660	1110	1117	history	T033	C1287400
28057660	1121	1139	epileptic seizures	T047	C0014544
28057660	1155	1165	craniotomy	T061	C0010280
28057660	1169	1186	burr hole surgery	T061	C0040836
28057660	1210	1224	Intraoperative	T079	C0456904
28057660	1225	1235	glycocalyx	T026	C0061622
28057660	1236	1245	thickness	T080	C1280412
28057660	1262	1272	sublingual	T029	C0026638
28057660	1274	1282	cortical	T023	C0007776
28057660	1287	1298	hippocampal	T023	C0019564
28057660	1299	1315	microcirculation	T042	C0025962
28057660	1333	1349	video microscopy	T059	C0242940
28057660	1356	1385	sidestream dark-field imaging	T060	C0011923
28057660	1387	1406	Demographic details	T185	C1698647
28057660	1408	1415	seizure	T184	C0036572
28057660	1416	1431	characteristics	T080	C1521970
28057660	1433	1441	epilepsy	T078	C1512571
28057660	1442	1454	risk factors	T033	C0035648
28057660	1456	1470	intraoperative	T079	C0456904
28057660	1456	1470	intraoperative	T079	C0456904
28057660	1471	1483	haemodynamic	T042	C0019010
28057660	1484	1494	parameters	T077	C0549193
28057660	1499	1516	histopathological	T169	C0243140
28057660	1517	1527	evaluation	T062	C0936012
28057660	1560	1568	protocol	T170	C2348563
28057660	1588	1596	approved	T080	C0205540
28057660	1604	1635	local medical ethical committee	T097	C0085546
28057660	1661	1669	complies	T169	C4281991
28057660	1679	1743	Declaration of Helsinki and principles of Good Clinical Practice	T170	C2986419
28057660	1754	1761	consent	T169	C1511481
28057660	1781	1786	study	T062	C2603343
28057660	1806	1816	coded data	T078	C1547332
28057660	1845	1853	database	T170	C0242356
28057660	1867	1878	audit trail	T078	C3858570
28057660	1880	1887	Results	T169	C1274040
28057660	1896	1905	submitted	T169	C1515023
28057660	1909	1945	international peer-reviewed journals	T170	C2985503
28057660	1963	1976	international	T078	C1512888
28057660	1977	1988	conferences	T068	C0086047